Search

everythinglearnresearchcommunity

for

Search:↓

Age, hair loss duration, menopause, and specific treatments affect hair density and caliber in female hair loss patients.

Experts recommend thorough medical, sexual, and psychosocial assessments for women's sexual dysfunctions, and suggest individualized treatment plans with regular check-ups. They also mention potential use of estrogen and androgen therapy, but with caution due to safety concerns.

People who are more materialistic often expect life changes from buying things, leading to more debt and credit misuse.

Traction alopecia is more common in African women than girls, especially when traction is applied to chemically relaxed hair; avoiding such hairstyles may reduce the risk.

Nearly half of the French individuals surveyed reported having a sensitive scalp, more common in women, often linked to hair loss and symptoms like itching, and triggered by factors including shampoos and pollution.

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Alopecia in captive rhesus macaques is affected by season, sex, age, housing, and stress, with complex links between stress hormones and hair loss.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

Hormonal therapies are safe and effective for treating adult women's acne.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

Men with testicular cancer were less likely to experience baldness and severe acne.

Hair loss in women not always linked to increased oil production; other factors may be involved.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.

Dental erosion is common in adolescents and is linked to diet and higher socioeconomic status.

Patients with rapidly progressive alopecia areata often have a better outlook and shorter disease duration, with regrown fine hairs and no past alopecia being positive signs.

Alopecia areata significantly lowers quality of life, especially in personal and social areas, and more so if the patient is also depressed.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Yellow and orange colors are important for diagnosing certain skin conditions.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

High levels of male hormones are very common in women with PCOS and affect their metabolism differently depending on their weight.

Type 2 diabetes may increase the risk of severe hair loss in African American women.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Certain hair straighteners and dyes may increase ovarian cancer risk, especially in African American/Black women.

Healthcare providers need better understanding and cultural sensitivity to improve care for transgender patients with kidney failure needing transplants.